Tempest Therapeutics (TPST) Long-Term Investments (2013 - 2018)
Tempest Therapeutics (TPST) posted Long-Term Investments of $140000.0 for Q3 2018, down 1.41% sequentially from $142000.0 in Q2 2018.
Tempest Therapeutics (TPST) Long-Term Investments (2013 - 2018) Analysis & Trends
Tempest Therapeutics has reported Long-Term Investments for 6 years, with the latest figure at $140000.0 in Q3 2018.
- Quarterly Long-Term Investments changed N/A year-over-year to $140000.0 in Q3 2018, while the trailing twelve-month figure through Sep 2018 was $140000.0 (changed N/A YoY) and the FY2017 annual result came in at $146000.0, up 124.62% from the prior year.
- Long-Term Investments slipped to $140000.0 in Q3 2018 per TPST's latest filing, from $142000.0 in the prior quarter.
- Over five years, Long-Term Investments peaked at $1.4 million in Q1 2014 and troughed at $65000.0 in Q4 2016.
- A 5-year average of $413769.2 and a median of $215000.0 in 2016 frame the typical range for Long-Term Investments.
- The sharpest annual moves came in 2015 and 2017: Long-Term Investments tumbled 86.03% in 2015, then jumped 124.62% in 2017.
- Over 5 years, Long-Term Investments stood at $585000.0 in 2014, then plunged by 58.8% to $241000.0 in 2015, then plunged by 73.03% to $65000.0 in 2016, then surged by 124.62% to $146000.0 in 2017, then decreased by 4.11% to $140000.0 in 2018.
- According to Business Quant data, Long-Term Investments over the past three periods registered $140000.0, $142000.0, and $146000.0 for Q3 2018, Q2 2018, and Q1 2018 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 5.79 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 9.83 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 1.77 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 22.17 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 372.10 Mn |
| 10 | Tempest Therapeutics | 4.32 Mn | 3.52 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | 140,000.00 |
| Jun 30, 2018 | 142,000.00 |
| Mar 31, 2018 | 146,000.00 |
| Dec 31, 2017 | 146,000.00 |
| Dec 31, 2016 | 65,000.00 |
| Sep 30, 2016 | 435,000.00 |
| Mar 31, 2016 | 215,000.00 |
| Sep 30, 2015 | 241,000.00 |
| Jun 30, 2015 | 557,000.00 |
| Mar 31, 2015 | 196,000.00 |
| Sep 30, 2014 | 585,000.00 |
| Jun 30, 2014 | 1.11 Mn |
| Mar 31, 2014 | 1.40 Mn |
| Dec 31, 2013 | 1.50 Mn |